Sarissa Capital seeks to oust Ariad Pharma CEO-Reuters

Sarissa Capital Management LP kicked off a proxy battle with Ariad Pharmaceuticals Inc on Friday, demanding the retirement of Harvey Berger, the drugmaker's chief executive and principal founder, Reuters reported.

20 February 2015•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles